Biggest News Aggregation in the World
๐Ÿ“ฐ Genetics Inc News

Page 2 - Genetics Inc News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Genetics Inc. Real-time updates on events, politics, business and more.

Myriad Genetics (NASDAQ:MYGN) Price Target Increased to $28.00 by Analysts at Piper Sandler

Myriad Genetics (NASDAQ:MYGN – Free Report) had its target price increased by Piper Sandler from $23.00 to $28.00 in a research note issued to investors on Monday morning, Benzinga reports. The brokerage currently has a neutral rating on the stock. Several other equities research analysts have also issued reports on MYGN. Leerink Partnrs upgraded shares […]
United States Leerink Partnrs Piper Sandler Paulj Diaz Blue Trust Inc Ameritas Investment Partners Inc
Source: wkrb13.com

Personalized Medicine Biomarkers Market Size and Trends 2024- Exploring Projected Growth at 16.3% CA

Marketresearch.biz reports that the The global Personalized Medicine Biomarkers Market was valued at USD 15.5 Billion in 2022. It is expected to reach USD 67.6 Billion by 2032, with a CAGR of 16.3% during the forecast period from 2023 to 2032.Overview of the Personalized Medicine Biomarkers MarketThe Personalized Me...
New York United States United Kingdom Asia Pacific Lawrence John Siemens Healthineers

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Myriad Genetics, Inc. (NASDAQ:MYGN) CEO Paul J. Diaz Sells 57,844 Shares of Stock

Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) CEO Paul J. Diaz sold 57,844 shares of the business’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $25.13, for a total transaction of $1,453,619.72. Following the transaction, the chief executive officer now directly owns 1,236,166 shares of […]
United States New Zealand General New Zealand Leerink Partnrs Paulj Diaz Piper Sandler
Source: wkrb13.com

New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer

Myriadโ€™s Prolaris Test is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1 SALT LAKE CITY, May 16, 2024 -- Myriad Genetics, Inc. , a...
United States Dale Muzzey Matt Scalo Glenn Farrell American Society Of Clinical Oncology University Of Utah

Federated Hermes Inc. Sells 1,533 Shares of Myriad Genetics, Inc. (NASDAQ:MYGN)

Federated Hermes Inc. decreased its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 55,009 shares of the company’s stock after selling 1,533 shares during the quarter. […]
United States New Zealand General New Zealand Goldman Sachs Group Qube Research Technologies Ltd Invesco Ltd

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science